Expect a significant appreciation in price leading up to the upcoming poster presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR virtual annual meeting.
הערה:
Large MACD divergence into what seems like price consolidation. Expecting a big move within the next 3-5 days.
